Stock Analysis | DuPont de Nemours Outlook - Technical Signals Point to Weak Momentum Amid Mixed Analyst Outlooks

Market Snapshot

Headline Takeaway: DuPont de Nemours (DD) faces a weak technical outlook with no bullish signals and five bearish indicators, while analyst ratings remain mixed and fundamentals show moderate strength. Stance: Cautious.

News Highlights

Recent news impacting the broader market and potential indirect effects on DD include:

• U.S. changes to COVID-19 vaccine policy: The Department of Health and Human Services has shifted its approach to vaccine approvals, which could influence broader market sentiment and consumer confidence, indirectly affecting DD's chemical and materials markets.
• Trump fast-tracks Utah uranium mine: A policy shift under President Trump may impact the energy and mining sectors, though uranium prices must rise significantly for the industry to benefit meaningfully.
• REX Shares files for Ethereum and Solana ETFs: The crypto space is evolving with potential regulatory clarity, which might boost risk-on sentiment and indirectly benefit large-cap industrial stocks like DD.

Analyst Views & Fundamentals

The analyst consensus for DD shows a simple average rating of 4.33 and a performance-weighted rating of 3.85. Despite three active institutions (RBC Capital, Keybanc, UBS), ratings are inconsistent, with recent recommendations ranging from "Buy" to "Strong Buy."

Analyst ratings do not fully align with DD’s recent price trend. While the stock has risen by 3.49% in the last five days, the technical outlook is weak, and the average historical win rate among analysts is 60.4%. This suggests that while the market is up, the broader analyst outlook is relatively cautious.

Key fundamental factors and their corresponding internal diagnostic scores (0-10) are as follows:

• Net cash flow from operating activities per share (YoY growth rate %): 18.59% – Internal diagnostic score: 3
• Current assets turnover ratio: 0.96 – Internal diagnostic score: 3
• Cash-UP: 0.16 – Internal diagnostic score: 2
• Current ratio: 1.41 – Internal diagnostic score: 2
• Cost of sales ratio: 62.64% – Internal diagnostic score: 2
• Cash-MV: -0.85 – Internal diagnostic score: 3

While some metrics like net cash flow and current ratio are relatively healthy, the cost of sales ratio remains high, which may pressure profit margins. The overall fundamental score is 6.69, indicating moderate strength, but with room for improvement.

Money-Flow Trends

Big-money investors appear cautious, with block, large, and extra-large investor flows trending negatively. The overall inflow ratio is 0.4877, meaning just under half of capital is flowing in. However, retail investors are more active, with a small investor inflow ratio of 0.5032 and a positive trend.

The fund-flow score is 7.73 (good), suggesting that while institutional flows are bearish, retail flows are pushing for accumulation. This divergence may indicate market uncertainty.

Key Technical Signals

DuPont de Nemours’ technical score is 1.67, indicating a weak technical outlook. Here are the key signals:

• WR Overbought – Internal diagnostic score: 2.52 (neutral rise), historically associated with a 46.3% win rate and an average return of 0.16%.
• RSI Overbought – Internal diagnostic score: 1.66 (biased bearish), with a historical win rate of 38.5% and average return of -0.36%.
• Ex-Dividend Date – Internal diagnostic score: 1.00 (biased bearish), historically associated with -0.33% average return and a 25% win rate.
• Dividend Record Date – Internal diagnostic score: 1.00 (biased bearish), with a 25% win rate and -0.33% average return.
• Bullish Engulfing – Internal diagnostic score: 2.19 (neutral bias), but with a -0.29% average return and 40% win rate.

Recent indicators by date (last 5 days):

• 2025-08-26: WR Overbought, Bullish Engulfing
• 2025-08-27: WR Overbought, RSI Overbought
• 2025-08-29: Ex-Dividend Date, Dividend Record Date

The technical trend is bearish, with 5 bearish vs. 0 bullish indicators. The key insight is that the technical side is weak, and investors are advised to avoid the stock in the near term.

Conclusion

While fundamentals and analyst ratings suggest moderate strength, the technical outlook is weak and bearish indicators dominate. With institutional flows trending negative and internal diagnostic scores under 2.0 for key bearish signals, DD appears to be in a vulnerable position.

Actionable takeaway: Investors should consider avoiding DuPont de Nemours for now, especially as the technical environment suggests a high risk of further decline. Those with a long-term view may want to monitor key earnings and cash flow developments, but near-term caution is warranted.